Iptacopan (LNP023) clinical trials

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

This study is testing a new medicine, Iptacopan, to see if it can stop or slow down age-related macular degeneration (AMD). Researchers are looking at people with early or intermediate AMD in one eye and a more advanced type in the other eye.